drugset / Trial / NCT04691570
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)
NaSingle-groupOpen-labelTreatment
Summary
This study will evaluate the safety and tolerability of ANX005 in participants with Warm Autoimmune Hemolytic Anemia (wAIHA).
Timeline
- Start
- 2021-11-10
- Primary completion
- 2023-01-17
- Completion
- 2023-01-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ANX005 | Protein / enzyme biologic | — | Intravenous |